Clinical Trials Logo

Ventricular Dysfunction, Left clinical trials

View clinical trials related to Ventricular Dysfunction, Left.

Filter by:

NCT ID: NCT00939042 Terminated - Clinical trials for Acute Myocardial Infarction

Alster Stem Cells - Intramyocardial Stem Therapy

Start date: January 2009
Phase: N/A
Study type: Interventional

Study to assess the efficacy of intramyocardial bone marrow derived mononuclear cell therapy concerning left ventricular ejection fraction as measured by echocardiography.

NCT ID: NCT00872001 Terminated - Stroke Clinical Trials

The Effect Of Acadesine On Reducing Cardiovascular and Cerebrovascular Adverse Events In Coronary Artery Bypass Graft (CABG) Surgery (Study P05633 AM1)(TERMINATED)

RED-CABG
Start date: April 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether acadesine is effective in reducing the cardiovascular and cerebrovascular adverse events in high-risk participants undergoing CABG surgery.

NCT ID: NCT00587990 Terminated - Clinical trials for Stem Cell Transplantation

Prospective Randomized Study of Mesenchymal Stem Cell Therapy in Patients Undergoing Cardiac Surgery (PROMETHEUS)

PROMETHEUS
Start date: November 2007
Phase: Phase 1/Phase 2
Study type: Interventional

Heart attacks are a leading cause of death in both men and women in the United States. When a person has a heart attack, blood is unable to reach a certain area of the heart, and if the blood supply is not re-established quickly, that area of the heart can suffer permanent damage. While recovery from a heart attack can be managed through medications and lifestyle changes, these treatments can not reverse the original damage to the heart. Current research is focusing on the development of cell-based therapies using stem cells to repair organs that have been irreversibly damaged by disease. A specific form of stem cells, called adult mesenchymal stem cells (MSCs), has shown promise for heart repair. This study will evaluate the safety and effectiveness of injecting MSCs into the heart to repair and restore heart function in people who have had a heart attack and who are having heart surgery for coronary artery bypass grafting (CABG).

NCT ID: NCT00487279 Terminated - Clinical trials for Coronary Artery Disease

DEfibrillators To REduce Risk by MagnetIc ResoNance Imaging Evaluation

DETERMINE
Start date: June 2007
Phase: N/A
Study type: Interventional

This trial is a prospective, multi-center, randomized study of patients with coronary artery disease (CAD) and mild to moderate left ventricular (LV) dysfunction. The primary objective of this study is to test the hypothesis that Implantable Cardioverter Defibrillator (ICD) therapy in combination with medical therapy in patients with an infarct size greater than or equal to 10% of the left ventricular mass improves long term survival compared to medical therapy alone. In addition to the 2-arm randomized trial, the study will also include a non-investigational registry of non-randomized patients.